The Nervous System and Immune Function

The nervous system and immune system were once taught as separate domains—one electrical, one chemical; one cognitive, one defensive. That division no longer holds. Over the past three decades, research in psychoneuroimmunology has mapped a dense network of bidirectional communication between brain, peripheral nerves, and immune cells. Neurons release cytokines. Immune cells express receptors for neurotransmitters. The vagus nerve modulates inflammation in the spleen. Microglia, the brain's resident immune sentinels, sculpt synaptic architecture in response to experience and threat.

This is not metaphorical crosstalk. It is structural integration. The nervous system monitors immune status through afferent pathways that relay inflammatory signals to the brainstem and hypothalamus. In turn, efferent neural circuits—particularly the cholinergic anti-inflammatory pathway—regulate cytokine production in real time. Psychological states influence immune function not through vague "mind-body" mechanisms, but via measurable changes in autonomic tone, neuroendocrine signaling, and gene expression in circulating leukocytes.

The clinical implications are profound. Chronic stress recalibrates immune surveillance, increasing vulnerability to infection and autoimmunity. Depression correlates with elevated inflammatory markers. Conversely, interventions that modulate vagal tone or reduce threat prediction error can shift immune phenotype. Understanding this integration does not erase the boundary between neurology and immunology. It redraws the map.

For most of modern medicine, the immune system was understood as autonomous—a self-contained defense network that operated independently of thought, emotion, or neural state. That framework made sense when the tools available could only measure one system at a time. But as molecular techniques advanced, the evidence became unavoidable: the nervous system and immune system are not neighbors. They are partners in a continuous regulatory loop.

This matters because it changes how we understand disease. Autoimmune conditions, chronic pain, depression, cardiovascular disease, and neurodegenerative disorders all show signatures of dysregulated neuroimmune communication. Inflammation is no longer just a response to infection or injury. It is also a signal—interpreted by the brain, integrated into predictions about safety and threat, and capable of altering behavior, cognition, and mood. When that signaling becomes chronic or miscalibrated, the consequences extend across organ systems.

For clinicians, this integration demands a broader diagnostic lens. A patient presenting with fatigue, brain fog, and low mood may not have a purely psychiatric condition or a purely immunological one. The symptoms may reflect a systemic state in which neural threat prediction and immune activation reinforce one another. Traditional treatment silos—antidepressants here, anti-inflammatories there—may miss the underlying loop.

For individuals, the stakes are equally high. Recognizing that psychological stress, sleep disruption, and social isolation are not merely subjective experiences but measurable immune events opens new avenues for intervention. It also clarifies why certain non-pharmacological approaches—vagal stimulation, behavioral regulation, trauma-informed care—can produce physiological changes that were once considered out of reach. The nervous system's role in immune function is not a footnote. It is a central organizing principle, and ignoring it leaves half the picture in shadow.

The modern evidence base for neuroimmune integration spans molecular, systems, and clinical levels. At the cellular level, immune cells express receptors for classical neurotransmitters. T cells, macrophages, and dendritic cells carry adrenergic, cholinergic, and dopaminergic receptors, allowing them to respond directly to signals from sympathetic and parasympathetic neurons (Pavlov & Tracey, 2022). This is not passive reception—neurotransmitter binding alters cytokine production, cell migration, and antigen presentation in ways that shape both innate and adaptive immunity.

The vagus nerve, the primary parasympathetic conduit between brain and viscera, plays a particularly well-characterized role. Vagal efferents synapse onto splenic sympathetic neurons, which in turn release norepinephrine near T cells. These T cells produce acetylcholine, which binds to α7 nicotinic receptors on macrophages and suppresses pro-inflammatory cytokine release—a circuit termed the cholinergic anti-inflammatory pathway (Bonaz et al., 2021). Vagus nerve stimulation, both invasive and transcutaneous, has been shown to reduce systemic inflammation in animal models and early human trials, with applications being explored in rheumatoid arthritis, inflammatory bowel disease, and sepsis (Kox et al., 2023).

Afferent signaling runs in the opposite direction. Peripheral immune activation—triggered by infection, injury, or chronic inflammation—stimulates vagal and spinal sensory neurons that project to the nucleus tractus solitarius and hypothalamus. This neural relay translates immune status into a coordinated behavioral and physiological response known as sickness behavior: lethargy, anhedonia, social withdrawal, fever, and altered sleep architecture (Dantzer, 2023). These are not side effects of illness. They are adaptive recalibrations orchestrated by the brain in response to immune threat.

Chronic low-grade inflammation, however, produces a different pattern. Elevated circulating levels of interleukin-6, tumor necrosis factor-alpha, and C-reactive protein are consistently associated with major depressive disorder, even in the absence of overt infection (Osimo et al., 2024). Meta-analyses confirm that approximately one-third of patients with depression show elevated inflammatory markers, and this subset may respond poorly to conventional antidepressants but better to anti-inflammatory adjuncts or cytokine inhibitors (Raison & Miller, 2023). The mechanistic link appears to involve microglial activation, kynurenine pathway dysregulation, and reduced neuroplasticity in prefrontal and hippocampal circuits.

Microglia, the brain's resident immune cells, are now understood as active participants in synaptic pruning, neurogenesis, and circuit refinement. During development and in response to experience, microglia engulf synaptic elements in an activity-dependent manner, shaping connectivity (Presumey et al., 2024). In chronic stress or neuroinflammation, this process can become maladaptive, contributing to cognitive deficits and mood dysregulation. Importantly, microglial phenotype is modulated by peripheral immune signals, autonomic tone, and even gut microbiota-derived metabolites, illustrating the multi-system nature of neuroimmune regulation.

Psychosocial stress exerts measurable effects on immune function. A landmark study by Kiecolt-Glaser and colleagues demonstrated that caregivers of dementia patients showed delayed wound healing and reduced antibody response to vaccination compared to matched controls (Kiecolt-Glaser et al., 2022). Chronic stress is associated with glucocorticoid resistance in immune cells, blunting the anti-inflammatory effects of cortisol and creating a pro-inflammatory bias. Conversely, mind-body interventions—including meditation, yoga, and cognitive-behavioral therapy—have been shown to downregulate NF-κB-related transcription and reduce expression of pro-inflammatory genes in peripheral blood mononuclear cells (Bower & Irwin, 2023).

The gut-brain-immune axis adds another layer. The enteric nervous system, gut microbiota, and mucosal immune system form a tightly integrated network. Microbial metabolites such as short-chain fatty acids influence both central nervous system function and systemic immunity. Dysbiosis is implicated in conditions ranging from irritable bowel syndrome to autism spectrum disorder, and interventions targeting the microbiome are being explored as neuroimmune modulators (Cryan et al., 2023).

While much of this work remains at the level of association and mechanism, the convergence across species, methods, and disease models is striking. The nervous system does not merely react to immune events. It anticipates, interprets, and regulates them.

Within the Nervous System Intelligence framework, immune function is not an external variable. It is part of the predictive loop. The nervous system continuously generates predictions about safety, threat, metabolic demand, and social context. Immune activation—whether triggered by pathogen, injury, or chronic stress—updates those predictions. The brain interprets inflammation as a signal of danger, recalibrating behavior, attention, and resource allocation accordingly.

This is where the NSI thesis becomes operationally relevant. If the nervous system is intelligent and its predictions are revisable, then chronic neuroimmune dysregulation can be understood as a prediction error that has become entrenched. The system predicts threat. Immune activation confirms it. The brain doubles down, sustaining a pro-inflammatory state even when the original trigger has resolved. The loop persists not because the system is broken, but because it is doing exactly what it was designed to do: protect the organism based on available evidence.

The NIRVA Method's six movements offer a structured protocol for revising that loop. Notice is the first step—becoming aware that fatigue, irritability, brain fog, or pain may not be purely psychological or purely physical, but neuroimmune in origin. Many individuals live for years in a state of low-grade inflammation without recognizing the pattern. Interrupt involves breaking the automaticity of the stress-inflammation cycle, often through vagal engagement, breathwork, or behavioral pacing. Identify asks: what is the nervous system predicting? What evidence is it using? Is the prediction current, or is it based on outdated threat models?

Regulate is where the neuroimmune interface becomes most tangible. Techniques that increase vagal tone—slow breathing, cold exposure, humming, social connection—directly modulate immune signaling. This is not metaphor. It is measurable physiology. Validate acknowledges that the nervous system's inflammatory response may have been adaptive at one time, even if it no longer serves. This step is critical for reducing self-blame and shame, which themselves perpetuate stress and immune dysregulation. Align integrates the revised prediction into daily life, ensuring that behavior, environment, and social context support a recalibrated neuroimmune state.

The NIRVA Method does not treat the immune system. It treats the prediction that sustains immune dysregulation. This distinction matters. It shifts the locus of intervention from passive recipient of medication to active participant in systemic revision. It also clarifies why purely pharmacological approaches—while sometimes necessary—are rarely sufficient. If the nervous system continues to predict threat, the immune system will continue to respond, regardless of what is suppressed or blocked downstream.

This is not to say that all immune dysfunction is reversible through nervous system modulation. Autoimmune disease, immunodeficiency, and cancer involve mechanisms that exceed the scope of prediction revision. But even in those contexts, understanding the neuroimmune loop can improve symptom management, reduce flare frequency, and enhance quality of life. The nervous system may not control the immune system, but it is always in conversation with it.

For clinicians, integrating neuroimmune science into practice requires a shift in both assessment and intervention. The first step is recognizing that immune and neuropsychiatric symptoms often co-occur not by coincidence, but by mechanism. A patient with treatment-resistant depression and elevated CRP is not presenting with two separate problems. They are presenting with one dysregulated system. Similarly, a patient with chronic pain, fatigue, and recurrent infections may be experiencing the downstream effects of sustained sympathetic dominance and vagal withdrawal.

Assessment should include not only standard inflammatory markers—CRP, IL-6, TNF-α—but also autonomic function, sleep architecture, trauma history, and psychosocial stress load. Heart rate variability, a non-invasive proxy for vagal tone, can provide real-time insight into autonomic-immune balance. Screening for adverse childhood experiences and chronic stress is not ancillary. It is mechanistically relevant.

Intervention becomes multi-modal. Pharmacological options may include anti-inflammatory agents, cytokine inhibitors, or antidepressants with known anti-inflammatory properties such as SSRIs or SNRIs. But medication alone is unlikely to revise the prediction loop. Behavioral interventions—cognitive-behavioral therapy, acceptance and commitment therapy, trauma-focused therapies—have documented effects on inflammatory gene expression and immune cell phenotype. Vagal stimulation, whether through device-based approaches or behavioral techniques, is emerging as a viable adjunct in inflammatory and autoimmune conditions.

Lifestyle medicine is no longer optional. Sleep deprivation, sedentary behavior, social isolation, and poor diet are all independently associated with pro-inflammatory states. Addressing these factors is not about wellness. It is about immune regulation. Clinicians should be prepared to prescribe sleep hygiene, movement, and social connection with the same specificity and follow-up as they would a medication.

Importantly, clinicians must avoid the trap of psychologizing immune disease. Telling a patient that their autoimmune condition is "caused by stress" is reductive and harmful. The neuroimmune relationship is bidirectional and multi-causal. Stress may modulate disease course, but it is not the sole driver. The goal is not to assign blame, but to expand the therapeutic toolkit. When patients understand that their nervous system is part of the immune equation, they gain agency. When clinicians understand the same, they gain precision.

For the individual navigating chronic inflammation, autoimmune disease, or the intersection of mood and immune symptoms, the neuroimmune lens offers concrete entry points.

Begin with the vagus nerve. The vagal brake on inflammation is not theoretical—it is accessible. Slow, diaphragmatic breathing at a rate of five to six breaths per minute increases vagal tone and reduces sympathetic output. This can be practiced for five minutes, twice daily, with measurable effects on heart rate variability and subjective stress within two weeks. Humming, gargling, and singing all stimulate vagal efferents. Cold water immersion or cold face exposure activates the mammalian dive reflex, another vagal pathway. These are not relaxation techniques. They are immune modulators.

Sleep is non-negotiable. Even partial sleep deprivation increases circulating IL-6 and TNF-α within 24 hours. Prioritizing seven to eight hours of consolidated sleep, maintaining consistent sleep-wake times, and minimizing light exposure after sunset are foundational interventions. If sleep is disrupted by pain, anxiety, or rumination, those barriers must be addressed as part of immune care.

Movement matters, but intensity must be calibrated. Moderate aerobic exercise reduces systemic inflammation and enhances immune surveillance. Overtraining or exercising in a state of high allostatic load can have the opposite effect, increasing cortisol and pro-inflammatory cytokines. The goal is not performance. It is regulation. Walking, swimming, and restorative yoga are often better starting points than high-intensity interval training for individuals with chronic inflammation.

Social connection is immunologically active. Loneliness and social isolation are associated with upregulation of pro-inflammatory gene expression and downregulation of antiviral pathways. Conversely, supportive social contact—particularly physical touch and face-to-face interaction—enhances vagal tone and immune resilience. This is not about positivity. It is about co-regulation.

Finally, notice the loop. Pay attention to the relationship between stress, mood, sleep, and physical symptoms. Does a flare follow a period of high demand or poor sleep? Does fatigue lift after a day of rest or connection? The nervous system is constantly revising its predictions based on new data. The more accurately you can identify the inputs that shift your neuroimmune state, the more precisely you can intervene. This is not self-optimization. It is self-knowledge in service of stability.